Article
CYP1A1 polymorphisms and lung cancer risk: a meta-analysis.
Pharmacogenetics - 1 Mar 2000
Houlston R S
Abstract excerpt
To examine the risk of lung cancer associated with the MspI-restriction fragment length polymorphism and Exon7-Val polymorphisms of CYP1A1, a meta-analysis of published case-control studies was undertaken using a random effects model. The principal outcome measure was the odds ratio for the risk of lung cancer, using homozygosity of the 'wild-type allele' as the reference group. Fifteen reports detailing the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
